Lantern Pharma Inc. (LTRN) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LTRN Revenue Growth
LTRN Revenue Analysis (2018–2024)
As of May 8, 2026, Lantern Pharma Inc. (LTRN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, LTRN's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ONCO (-67.7% YoY), CASI (+21.7% YoY), and RXRX (+11.0% YoY). Compare LTRN vs ONCO →
LTRN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LTRNCurrent | $0 | - | - | - | |
 ONCO | $815,371 | -67.7% | - | -778.2% | |
 CASI | $29M | +21.7% | +47.2% | -138.8% | |
 RXRX | $75M | +11.0% | +85.4% | -867.9% |
LTRN Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-22,216,437 | - |
| 2023 | $0 | - | $-174,843 | - | $-17,877,570 | - |
| 2022 | $0 | - | $0 | - | $-14,432,753 | - |
| 2021 | $0 | - | $0 | - | $-12,591,508 | - |
| 2020 | $0 | - | $0 | - | $-5,908,190 | - |
| 2019 | $0 | - | $-1,627 | - | $-2,428,185 | - |
| 2018 | $0 | - | $3K | - | $-1,726,417 | - |
See LTRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LTRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LTRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLTRN — Frequently Asked Questions
Quick answers to the most common questions about buying LTRN stock.
Is LTRN's revenue growth accelerating or slowing?
LTRN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is LTRN's long-term revenue growth rate?
Lantern Pharma Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is LTRN's revenue distributed by segment?
LTRN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.